Quadrant Capital Group LLC Bristol Myers Squibb CO Transaction History

Quadrant Capital Group LLC

  • $2.65 Billion
  • Q1 2025

A detailed history of Quadrant Capital Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quadrant Capital Group LLC holds 34,540 shares of BMY stock, worth $1.62 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
34,540
Previous 12,916 167.42%
Holding current value
$1.62 Million
Previous $730,000 188.49%
% of portfolio
0.08%
Previous 0.05%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$53.9 - $63.11 $1.17 Million - $1.36 Million
21,624 Added 167.42%
34,540 $2.11 Million
Q4 2024

Feb 12, 2025
BUY
$51.92 - $59.94 $56,904 - $65,694
1,096 Added 9.27%
12,916 $730,000
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $151,897 - $198,202
3,830 Added 47.93%
11,820 $611,000
Q2 2024

Aug 12, 2024
SELL
$40.25 - $52.99 $142,042 - $187,001
-3,529 Reduced 30.64%
7,990 $331,000
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $144,275 - $163,580
-3,007 Reduced 20.7%
11,519 $624,000
Q4 2023

Feb 08, 2024
SELL
$48.48 - $57.85 $123,381 - $147,228
-2,545 Reduced 14.91%
14,526 $745,000
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $42,317 - $47,317
-731 Reduced 4.11%
17,071 $990,000
Q2 2023

Aug 09, 2023
SELL
$63.71 - $70.74 $256,496 - $284,799
-4,026 Reduced 18.44%
17,802 $1.14 Million
Q1 2023

May 11, 2023
SELL
$65.71 - $74.53 $103,953 - $117,906
-1,582 Reduced 6.76%
21,828 $1.51 Million
Q4 2022

Feb 10, 2023
BUY
$68.48 - $81.09 $415,742 - $492,297
6,071 Added 35.01%
23,410 $1.68 Million
Q3 2022

Nov 10, 2022
BUY
$0.13 - $76.84 $52 - $31,043
404 Added 2.39%
17,339 $1.23 Million
Q2 2022

Aug 09, 2022
BUY
$72.62 - $79.98 $76,541 - $84,298
1,054 Added 6.64%
16,935 $1.3 Million
Q1 2022

May 06, 2022
BUY
$61.48 - $73.72 $154,560 - $185,332
2,514 Added 18.81%
15,881 $1.16 Million
Q4 2021

Feb 01, 2022
SELL
$53.63 - $62.52 $19,843 - $23,132
-370 Reduced 2.69%
13,367 $833,000
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $15,620 - $18,297
-264 Reduced 1.89%
13,737 $813,000
Q2 2021

Aug 09, 2021
SELL
$61.91 - $67.42 $95,031 - $103,489
-1,535 Reduced 9.88%
14,001 $936,000
Q1 2021

May 12, 2021
BUY
$59.34 - $66.74 $149,299 - $167,917
2,516 Added 19.32%
15,536 $981,000
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $26,560 - $30,097
460 Added 3.66%
13,020 $808,000
Q3 2020

Nov 13, 2020
BUY
$57.43 - $63.64 $40,488 - $44,866
705 Added 5.95%
12,560 $757,000
Q2 2020

Aug 13, 2020
SELL
$54.82 - $64.09 $883,314 - $1.03 Million
-16,113 Reduced 57.61%
11,855 $697,000
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $13,873 - $20,161
-299 Reduced 1.06%
27,968 $1.56 Million
Q4 2019

Feb 03, 2020
BUY
$49.21 - $64.19 $580,924 - $757,762
11,805 Added 71.71%
28,267 $1.78 Million
Q3 2019

Oct 24, 2019
BUY
$42.77 - $50.71 $163,638 - $194,016
3,826 Added 30.28%
16,462 $822,000
Q2 2019

Jul 24, 2019
SELL
$44.62 - $49.34 $40,202 - $44,455
-901 Reduced 6.66%
12,636 $559,000
Q1 2019

Apr 29, 2019
BUY
$45.12 - $53.8 $165,364 - $197,177
3,665 Added 37.13%
13,537 $627,000
Q4 2018

Jan 17, 2019
SELL
$48.76 - $63.23 $27,890 - $36,167
-572 Reduced 5.48%
9,872 $494,000
Q3 2018

Oct 29, 2018
BUY
$55.19 - $62.25 $22,683 - $25,584
411 Added 4.1%
10,444 $630,000
Q2 2018

Aug 09, 2018
SELL
$50.53 - $62.98 $39,463 - $49,187
-781 Reduced 7.22%
10,033 $542,000
Q1 2018

May 10, 2018
SELL
$59.92 - $68.98 $19,474 - $22,418
-325 Reduced 2.92%
10,814 $662,000
Q4 2017

Jan 31, 2018
SELL
$59.94 - $65.35 $3,656 - $3,986
-61 Reduced 0.54%
11,139 $670,000
Q3 2017

Oct 13, 2017
BUY
$55.23 - $63.74 $8,229 - $9,497
149 Added 1.35%
11,200 $696,000
Q2 2017

Aug 15, 2017
BUY
N/A
11,051
11,051 $568,000

Others Institutions Holding BMY

# of Institutions
2,806
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email